Treating co-occurring first-episode psychosis and borderline personality: A pilot randomized controlled trial

Early Intervention in Psychiatry

Volumn 6, Issue 1, 2012, Pages 21-29

  Gleeson, John F M ^a   Chanen, Andrew ^b,c   Cotton, Sue M ^b   Pearce, Tracey ^c   Newman, Belinda ^b   McCutcheon, Louise ^b,c  

^a AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

Author keywords

Borderline personality disorder; Comorbidity; Early psychosis; First episode psychosis; RCT

Indexed keywords

ADOLESCENT; ADULT; AGGRESSION; ARTICLE; AUTOMUTILATION; BORDERLINE STATE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EARLY INTERVENTION; FEASIBILITY STUDY; FEMALE; FIRST EPISODE PSYCHOSIS; FOLLOW UP; HELPING YOUNG PEOPLE EARLY; HIGH RISK PATIENT; HUMAN; MALE; MEDICAL SPECIALIST; PATIENT SAFETY; PILOT STUDY; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SUICIDE;

ADOLESCENT; ADULT; BORDERLINE PERSONALITY DISORDER; COGNITIVE THERAPY; EARLY DIAGNOSIS; EARLY MEDICAL INTERVENTION; FEMALE; HUMANS; MALE; PATIENT DROPOUTS; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS;

EID: 84856351913     PISSN: 17517885     EISSN: 17517893     Source Type: Journal    
DOI: 10.1111/j.1751-7893.2011.00306.x     Document Type: Article

References (41)

1. McGorry PD, Killackey E, Yung A. Early intervention in psychosis: concepts, evidence and future directions. World Psychiatry 2008; 7: 148-56.
2. Bertelsen M, Jeppesen P, Petersen L etal. Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness. Arch Gen Psychiatry 2008; 65: 762-71.
3. National Collaborating Centre for Mental Health. Borderline personality disorder: treatment and management. NICE Clinical Guideline 78 National Institute for Health and Clinical Excellence, 2009.
4. Chanen AM, Jovev M, Djaja D etal. Screening for borderline personality disorder in outpatient youth. J Pers Disord 2008; 22: 353-64.
5. Korzekwa MI, Dell PF, Links PS, Thabane L, Webb SP. Estimating the prevalence of borderline personality disorder in psychiatric outpatients using a two-phase procedure. Compr Psychiatry 2008; 49: 380-6.
6. Newton-Howes G, Tyrer P, Moore A, Nur U. Personality disorder and outcome in schizophrenia: a negative systematic review. Pers Ment Health 2007; 1: 21-6.
7. Barnow S, Arens EA, Sieswerda S, Dinu-Biringer R, Spitzer C, Lang S. Borderline personality disorder and psychosis: a review. Curr Psychiatry Rep 2010; 12: 186-95.
8. Stone MH. Borderline personality disorder: history of the concept. In: Zanarini MC, ed. Borderline Personality Disorder. New York: Taylor and Francis, 2005; 1-18.
9. Moran P, Walsh E, Tyrer P, Burns T, Creed F, Fahy T. Does co-morbid personality disorder increase the risk of suicidal behaviour in psychosis? Acta Psychiatr Scand 2003; 107: 441-8.
10. Tyrer P, Manley C, Van Horn E, Leddy D, Ukoumunne OC. Personality abnormality in severe mental illness and its influence on outcome of intensive and standard case management: a randomised controlled trial. Eur Psychiatry 2000; 15: 7-10.
11. McGorry P, Killackey E, Lambert T etal. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Aust N Z J Psychiatry 2005; 39: 1-30.
12. Lilienfeld SO. Psychological treatments that cause harm. Perspect Psychol Sci 2007; 2: 53-70.
13. Fonagy P, Bateman A. Progress in the treatment of borderline personality disorder. Br J Psychiatry 2006; 188: 1-3.
14. Chanen AM, McCutcheon LK, Germano D, Nistico H, Jackson HJ, McGorry PD. The HYPE Clinic: an early intervention service for borderline personality disorder. J Psychiatr Pract 2009; 15: 163-72.
15. Ryle A, Kerr IB. Introducing Cognitive Analytic Therapy: Principles and Practice. Chichester, UK: Wiley, 2002.
16. Ryle A. The contribution of Cognitive Analytic Therapy to the treatment of borderline personality disorder. J Pers Disord 2004; 18: 3-35.
17. Chanen AM, Jackson HJ, McCutcheon L etal. Early intervention for adolescents with borderline personality disorder using Cognitive Analytic Therapy: a randomised controlled trial. Br J Psychiatry 2008; 193: 477-84.
18. Chanen AM, Jackson HJ, McCutcheon LK etal. Early intervention for adolescents with borderline personality disorder: quasi-experimental comparison with treatment as usual. Aust N Z J Psychiatry 2009; 43: 397-408.
19. Kerr IB, Birkett PBL, Chanen A. Clinical and service implications of a cognitive analytic therapy model of psychosis. Aust N Z J Psychiatry 2003; 37: 515-23.
20. McGorry PD, Edwards J, Mihalopoulos C, Harrigan SM, Jackson HJ. EPPIC: an evolving system of early detection and optimal management. Schizophr Bull 1996; 22: 305-26.
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Text Revision. Washington, DC: American Psychiatric Association, 2000.
22. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.
23. Lukoff D, Liberman RP, Nuechterlein KH. Symptom monitoring in the rehabilitation of schizophrenic patients. Schizophr Bull 1986; 12: 578-93.
24. Early Psychosis Prevention and Intervention Centre. Case Management in Early Psychosis: A Handbook. Parkville, Victoria, Australia: EPPIC, 2001.
25. First MB, Gibbon M, Spitzer RL, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Version (SCID-I/P). New York: Biometrics Research Department, New York State Psychiatric Institute, 1996.
26. First MB, Gibbon M, Spitzer R, Williams J etal. User's Guide for the Structured Clinical Interview for DSM-IV Axis II Personality Disorders. Washington DC: American Psychiatric Press, 1997.
27. Montgomery SM. Depressive symptoms in acute schizophrenia. Prog Neuropsychopharmacol 1979; 3: 429-33.
28. Andreasen NC. Scale for Assessment of Negative Symptoms (SANS). Iowa City: University of Iowa, 1984.
29. Coccaro EF, Harvey PD, Kupsaw-Lawrence E, Herbert JL, Bernstein DP. Development of neuropharmacologically based behavioral assessments of impulsive aggressive behavior. J Neuropsychiatry Clin Neurosci 1991; 3: S44-S51.
30. Coccaro E, Harvey P, Kupsaw L, Herbert J etal. Overt Aggression Scale Modified [OAS M]. In: Sajatovic M, Ramirez L, eds. Rating Scales in Mental Health. Hudson, OH: Lexi-Comp, 2001; 307-11.
31. Ali R, Awwad E, Babor T etal. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction 2002; 97: 1183-94.
32. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption - II. Addiction 1993; 88: 791-804.
33. Drake RE, Osher FC, Noordsy DL, Hurlbut SC, Teague GB, Beaudett MS. Diagnosis of alcohol use disorders in schizophrenia. Schizophr Bull 1990; 16: 57-67.
34. Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res 2000; 42: 241-7.
35. Goldman HH, Skodol AE, Lave TR. Revising Axis-V for DSM-IV - a review of measures of social functioning. Am J Psychiatry 1992; 149: 1148-56.
36. Gleeson JF, Cotton S, Alvarez-Jimenez M etal. A randomized controlled trial of CBT for relapse prevention for remitted first-episode psychosis patients. J Clin Psychiatry 2009; 70: 477-87.
37. Zimmerman M, Posternak MA, Chelminski I. Defining remission on the Montgomery-Asberg Depression Rating Scale. J Clin Psychiatry 2004; 65: 163-8.
38. Muller MJ, Himmerich H, Kienzle B, Szegedi A. Differentiating moderate and severe depression using the Montgomery-Asberg Depression Rating Scale (MADRS). J Affect Disord 2003; 77: 255-60.
39. McGorry PD. Issues for DSM-V: clinical staging: a heuristic pathway to valid nosology and safer, more effective treatment in psychiatry. Am J Psychiatry 2007; 164: 859-60.
40. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P, CONSORT Group. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 2008; 148: 295-309.
41. Allott K, Chanen A, Yuen HP. Attrition bias in longitudinal research involving adolescent psychiatric outpatients. J Nerv Ment Dis 2006; 194: 958-61.